SmartView Connect App - Implantable cardiac device management application software

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Microport Crm Pty Ltd

Classe:

Class III

Prodotto da:

MicroPort CRM S.r.l Via Crescentino sn, Saluggia, VC, 13040 Italy

Area terapeutica:

61680 - Implantable cardiac device management application software

Indicazioni terapeutiche:

The SmartView Connect application is part of the SmartView Remote Monitoring System (RMS), which is composed of the software itself installed on a off-the-shelf smartphone-like device and a back-office data management system controlled by MicroPort CRM. The purpose of the system is to remotely monitor MicroPort CRM implanted Bluetooth?-enabled pacemakers in patients? homes. The SmartView Connect App allows the remote monitoring of patients implanted with a MicroPort CRM Bluetooth? low energy-enabled pacemaker to treat symptomatic bradycardia. It is thus indicated in patients requiring atrial or ventricular pacing, or synchronous atrioventricular pacing.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2021-11-26